Connect your AI

BillionToOne, Inc. BLLN Contract Liabilities, Non-Current

Contract Liabilities, Non-Current at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

ExelixisEXEL

——

Crinetics PharmaceuticalsCRNX

——

Other financials

Income statement

Revenue$108.4M+83.8%

Gross profit$79.1M+108%

Operating income$17.8M+870%

Net income$18.0M+551%

EPS (diluted)$0.34+187%

Balance sheet

Cash & equivalents$537.5M+181%

Total debt$144.2M—

Total equity$505.6M+300%

Total assets$700.7M—

Cash flow

Operating cash flow$15.4M+488%

CapEx$4.5M+90.5%

Free cash flow$11.0M+3,842%

Valuation

Market cap$4.84B—

Profitability

Gross margin70.4%—

Operating margin-96.9%—

Net margin8.4%—

FCF margin-83.4%—

Returns & leverage

Debt / equity0.3×—

Current ratio10.9×—

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's contract liabilities, non-current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BillionToOne, Inc. 's contract liabilities, non-current?: BillionToOne, Inc. (BLLN) reported contract liabilities, non-current of $0 in Q1 2026.